Aptameric Modulation of Gadolinium (III) Contrast Agents
CSEF · 2011 Biochemistry/ Molecular Biology
Overview
Objectives/Goals This research investigates whether binding oligonucleotide-based receptors (aptamers) to gadolinium-based MRI contrast agents can increase the sensitivity of the contrast agents by increasing their relaxivity. It is a further objective of the investigation that the synthesized product interfere less with Ca2+ receptors in biological systems than existing gadolinium-based Magnetic Resonance Imaging (MRI). Methods/Materials These goals are achieved using a synthesized ligand and aptamers (synthetic, highly structured, single stranded DNA or RNA ligands). Increasing the molecular weight of contrast agents by binding them to a ligand and an aptamer should increase the relaxivity of the contrast agent and reduce the number of water molecules in the first coordination sphere. Binding the contrast agent to a DNA aptamer will also likely reduce the extent to which gadolinium competes with Ca2+ in biological systems. Results Currently, successful synthesis of all structures from the base of the ligands, all intermediary structures, and the fully-synthesized ligand has been confirmed using nuclear magnetic resonance and/or a mass spectrometer. Testing of both contrast agents shows no increase in clarity. Conclusions/Discussion The cause is still unknown; however, it creates new questions as to whether the library contained an aptamer with a high enough affinity, or if the protocol needed to be modified.
Summary statement
The purpose of this project was to design a more effective gadolinium based contrast agent by increasing the molecular weight.
Help received
Used lab at Columbia University under the supervision of Professor Milan Stojanovic and Marlin Halim.
Competition history
- CSEF 2011
Resources
Related projects
CSEF · 2011
A Contrasting Quandary: Optimizing the Signal Strengths of MRI Contrast Agents via Oligonucleotide Bridging
CSEF · 2011
A Theoretical Study to Increase Molecular Specificity in Nuclear Magnetic Resonance Spectra
CSEF · 2018
THY-1 Antibody Fragment Dye Contrast Agents for Novel Pancreatic Cancer Detection
CSEF · 2013
Improving Binding Affinity of the Calbindin-D9k Protein to Develop Efficient Calcium Biosensors
AJAS · 2026
Computational Design of Novel CD117-Specific RNA Aptamers for GBM Therapy
ISEF · 2025
Utilizing Protein Engineering to Develop a Neurotransmitter Sensor for MRI
CSEF · 2006
Synthesis and Biological Evaluation of a Glycoprotein as Antibacterial Agent
CSEF · 2017
Quantifying Binding Free Energies in Amyloid Systems Related to Alzheimer's and Enhancing Antibody Binding Affinities
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: California Science & Engineering Fair public projects